Similar articles

• [The clinical significance of the critical drug concentration of rifampicin. Report 2. Clinical investigation: the emergence and reversion of resistance (author's transl)].

  Baba H, Azuma Y. Baba H, et al. Kekkaku. 1976 Jan;51(1):7-12. Kekkaku. 1976. PMID: 815710 Japanese. No abstract available.
• [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].

  Kameda K, Okamura S, Yamamoto S, Iwai K. Kameda K, et al. Kekkaku. 1975 Jul;50(7):185-9. Kekkaku. 1975. PMID: 810614 Japanese. No abstract available.
• [Anti-mycobacterial activity of rifampicin].

  Gialdroni Grassi G. Gialdroni Grassi G. G Ital Mal Torace. 1971 Mar-Apr;25(2):77-88. G Ital Mal Torace. 1971. PMID: 5003253 Italian. No abstract available.
• Summation of experimental studies on the action of rifampin.

  Hobby GL. Hobby GL. Chest. 1972 Jun;61(6):550-4. doi: 10.1378/chest.61.6_supplement.550. Chest. 1972. PMID: 4624277 Review. No abstract available.
• [Pharmaceutical view of rifampicin (author's transl)].

  Tsutsumi S, Sakamoto Y, Gido S. Tsutsumi S, et al. Repura. 1974 Jan-Mar;43(1):1-7. doi: 10.5025/hansen1930.43.1_1. Repura. 1974. PMID: 4610307 Review. Japanese. No abstract available.